2019冠状病毒病对法国2020年移植活动及等候名单的影响。
Impact of COVID-19 on 2020 transplant activity and waiting lists in France.
作者信息
Legeai C, Savoye E, Cantrelle C, Jasseron C, Santin G, Brousse G, Duman M, Foubert F, Mahmoudi R, Deshayes A, Antoine C, Kerbaul F
机构信息
Organ and Tissue Procurement and Transplantation Department, Agence de la biomédecine, Saint Denis La Plaine, France.
Data Quality Department, Agence de la biomédecine, Saint Denis La Plaine, France.
出版信息
J Liver Transpl. 2022 Jan-Mar;5:100051. doi: 10.1016/j.liver.2021.100051. Epub 2021 Oct 23.
The COVID-19 pandemic strongly affected organ procurement and transplantation in France, despite the intense efforts of all participants in this domain. In 2020, the identification and procurement of deceased donors fell by 12% and 21% respectively, compared with the mean of the preceding 2 years. Similarly, the number of new registrations on the national waiting list declined by 12% and the number of transplants by 24%. The 3-month cumulative incidence of death or drop out for worsening condition of patients awaiting a liver transplant was significantly greater in 2020 compared to the previous 2 years. Continuous monitoring at the national level of early post-transplant outcomes showed no deterioration for any organ in 2020. At the end of 2020, less than 1% of transplant candidates and less than 1% of graft recipients - of any organ - had died of COVID-19.
尽管该领域的所有参与者都付出了巨大努力，但新冠疫情仍对法国的器官获取与移植产生了重大影响。2020年，与前两年的均值相比，已故捐赠者的识别和获取数量分别下降了12%和21%。同样，全国等待名单上的新登记人数下降了12%，移植手术数量下降了24%。与前两年相比，2020年等待肝移植患者因病情恶化导致死亡或退出的3个月累积发生率显著更高。2020年在国家层面持续监测移植后早期结果显示，任何器官的情况均未恶化。2020年底，任何器官的移植候选者和移植受者中死于新冠的比例均不到1%。
Zotero 插件